Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma

References

• Chaudhari K, Rizvi S, Syed BA. Non-Hodgkin lymphoma therapy landscape. Nat Rev Drug Discov. 2019;18(9):663–664. doi:10.1038/d41573-019-00051-6
   PubMed Web of Science ®Google Scholar
• Mottok A, Hung SS, Chavez EA, et al. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma. Blood. 2019;134(10):802–813. doi:10.1182/blood.2019001126
   PubMed Web of Science ®Google Scholar
• Larabi A, Barnich N, Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy. 2020;16:38–51.
   PubMed Web of Science ®Google Scholar
• Nesic M, EI-Galaly TC, Bøgsted M, et al. Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma. Expert Rev Hematol. 2020;13:655–668.
   PubMed Web of Science ®Google Scholar
• Furuse M, Kuwabara H, Ikeda N, et al. PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma. BMC Cancer. 2020;20(1):277. doi:10.1186/s12885-020-06755-y
   PubMed Web of Science ®Google Scholar
• Wang PY, Li JH, Liu YM, et al. Single nucleotide polymorphisms in ZNRD1-AS1 increase cancer risk in an Asian population. Oncotarget. 2017;8(6):10064–10070. doi:10.18632/oncotarget.14334
   PubMedGoogle Scholar
• Jiao J, Lv Z, Zhang P, et al. AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines. Neoplasia. 2020;22(3):142–153. doi:10.1016/j.neo.2020.01.002
   PubMed Web of Science ®Google Scholar
• Jiang XN, Yu BH, Yan WH, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression. Oncoimmunology. 2019;9(1):1683346. doi:10.1080/2162402X.2019.1683346
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell. 2016;165(4):792–800. doi:10.1016/j.cell.2016.03.046
   PubMed Web of Science ®Google Scholar
• Lavallard V, Cottet-Dumoulin D, Wassmer CH, et al. NLRP3 inflammasome is activated in rat pancreatic islets by transplantation and hypoxia. Sci Rep. 2020;10(1):7011. doi:10.1038/s41598-020-64054-9
   PubMed Web of Science ®Google Scholar
• Shinar Y, Ceccherini I, Rowczenio D, et al. ISSAID/EMQN best practice guidelines for the genetic diagnosis of monogenic autoinflammatory diseases in the next-generation sequencing era. Clin Chem. 2020;66(4):525–536. doi:10.1093/clinchem/hvaa024
   PubMed Web of Science ®Google Scholar
• Chen H, Deng Y, Gan X, et al. NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodegener. 2020;15(1):26. doi:10.1186/s13024-020-00372-w
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Sandstrom A, Vance RE. The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries. Curr Opin Immunol. 2019;60:37–45. doi:10.1016/j.coi.2019.04.015
   PubMed Web of Science ®Google Scholar
• Watany MM, Elmazny MI, Nasif EM. Interleukin-31 interaction with inflammasome: a promising diagnostic and prognostic panel for early sepsis identification in critically ill patients. Cytokine. 2020;131:155102. doi:10.1016/j.cyto.2020.155102
   PubMed Web of Science ®Google Scholar
• Yu JW, Lee MS. Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. Arch Pharm Res. 2016;39(11):1503–1518. doi:10.1007/s12272-016-0827-4
   PubMed Web of Science ®Google Scholar
• Xie C, Ge M, Jin J, et al. Mechanism investigation on bisphenol S-induced oxidative stress and inflammation in murine RAW264.7 cells: the role of NLRP3 inflammasome, TLR4, Nrf2 and MAPK. J Hazard Mater. 2020;394:122549. doi:10.1016/j.jhazmat.2020.122549
   PubMed Web of Science ®Google Scholar
• Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23(1):50. doi:10.1186/s12199-018-0740-1
   PubMed Web of Science ®Google Scholar
• Xiao FJ, Zhang D, Wu Y, et al. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis. Biochem Biophys Res Commun. 2019;515(3):448–454. doi:10.1016/j.bbrc.2019.05.147
   PubMed Web of Science ®Google Scholar
• Hu Z, Wu D, Zhao Y, et al. Inflammatory cytokine profiles in the crevicular fluid around clinically healthy dental implants compared to the healthy contralateral side during the early stages of implant function. Arch Oral Biol. 2019;108:104509. doi:10.1016/j.archoralbio.2019.104509
   PubMed Web of Science ®Google Scholar
• Sedimbi SK, Hägglöf T, Garimella MG, et al. Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses. Proc Natl Acad Sci USA. 2020;117(16):9054–9063. doi:10.1073/pnas.1920463117
   PubMed Web of Science ®Google Scholar
• Zhang A, Yu J, Yan S, et al. The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia. Hum Immunol. 2018;79(1):57–62. doi:10.1016/j.humimm.2017.10.013
   PubMed Web of Science ®Google Scholar
• Zhao X, Hua M, Yan S, et al. The genetic polymorphisms of NLRP3 inflammasome associated with T helper cells in patients with multiple myeloma. J Immunol Res. 2018;2018:7569809. doi:10.1155/2018/7569809
   PubMed Web of Science ®Google Scholar
• Wang H, Hua M, Wang S, et al. Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia. Inflamm Res. 2017;66(3):249–258. doi:10.1007/s00011-016-1012-4
   PubMed Web of Science ®Google Scholar
• Arima K, Komohara Y, Bu L, et al. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer. Cancer Sci. 2018;109(2):462–470. doi:10.1111/cas.13467
   PubMed Web of Science ®Google Scholar
• Shahzad MN, Ijaz I, Naqvi SSZH, et al. Association between interleukin gene polymorphisms and multiple myeloma susceptibility. Mol Clin Oncol. 2020;12(3):212–224.
   PubMed Web of Science ®Google Scholar
• Mendoza-Rodríguez MG, Ayala-Sumuano JT, García-Morales L, et al. IL-1β inflammatory cytokine-induced TP63 isoform ∆NP63α signaling cascade contributes to cisplatin resistance in human breast cancer cells. Int J Mol Sci. 2019;20(2):E270. doi:10.3390/ijms20020270
   PubMed Web of Science ®Google Scholar
• Moonen RM, Huizing MJ, Gonzalez-Luis GE, et al. Risk of necrotizing enterocolitis associated with the single nucleotide polymorphisms VEGF C-2578A, IL-18 C-607A, and IL-4 receptor α-chain A-1902G: a valiation study in a prospective multicenter cohort. Front Pediatr. 2020;8:45. doi:10.3389/fped.2020.00045
   PubMed Web of Science ®Google Scholar
• Yazdi AS, Ghoreschi K. The interleukin-1 family. Adv Exp Biol. 2016;941:21–29.
   PubMed Web of Science ®Google Scholar
• Roy K, Mitchell S, Liu Y, et al. A regulatory circuit controlling the dynamics of nfκb crel transitions b cells from proliferation to plasma cell differentiation. Immunity. 2019;50(3):616–628. doi:10.1016/j.immuni.2019.02.004
   PubMed Web of Science ®Google Scholar
• Chakraborty C, Sharma AR, Sharma G, et al. The interplay among miRNAs, major cytokines, and cancer-related inflammation. Mol Ther Nucleic Acids. 2020;20:606–620. doi:10.1016/j.omtn.2020.04.002
   PubMedGoogle Scholar
• Liu W, Guo W, Hang N, et al. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation. Oncotarget. 2016;7(21):30536–30549. doi:10.18632/oncotarget.8867
   PubMedGoogle Scholar
• Lazarian G, Friedrich C, Quinquenel A, et al. Stabilization of β-catenin upon B-cell receptor signaling promotes NF-κB target genes transcription in mantle cell lymphoma. Oncogene. 2020;39(14):2934–2947. doi:10.1038/s41388-020-1183-x
   PubMed Web of Science ®Google Scholar
• Chen F, Liu F, Yan L, et al. A functional haplotype of NFKB1 influence susceptibility to oral cancer: a population-based and in vitro study. Cancer Med. 2018;7(5):2211–2218. doi:10.1002/cam4.1453
   PubMed Web of Science ®Google Scholar
• Murakami S, Kato H, Higuchi Y, et al. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy. Ann Hematol. 2016;95(8):1259–1269. doi:10.1007/s00277-016-2690-2
   PubMed Web of Science ®Google Scholar